Imported Disease Annotations - ClinVarObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Kdr | Rat | colon carcinoma | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Carcinoma of colon | ClinVar | | Kdr | Rat | congenital disorder of glycosylation type IIk | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: TMEM165-CDG | ClinVar | PMID:22521416 more ... | Kdr | Rat | gastrointestinal stromal tumor | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Gastrointestinal stromal tumor | ClinVar | PMID:1279971 more ... | Kdr | Rat | hepatoblastoma | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Hepatoblastoma | ClinVar | PMID:28492532 | Kdr | Rat | High Myopia | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Severe Myopia | ClinVar | PMID:26422291 and PMID:28492532 | Kdr | Rat | Hirschsprung's disease | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Hirschsprung disease more ... | ClinVar | PMID:24728327 and PMID:28492532 | Kdr | Rat | Infantile Capillary Hemangioma | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Capillary infantile hemangioma | ClinVar | PMID:11807987 more ... | Kdr | Rat | primary ovarian insufficiency | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Premature ovarian failure | ClinVar | PMID:24728327 and PMID:25741868 | Kdr | Rat | prostate cancer | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Malignant tumor of prostate | ClinVar | PMID:23265383 | Kdr | Rat | teratoma | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Teratoma | ClinVar | | Kdr | Rat | tetralogy of Fallot | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Tetralogy of Fallot | ClinVar | | Kdr | Rat | Tufted Angioma | | ISO | KDR (Homo sapiens) | 8554872 | ClinVar Annotator: match by term: Tufted angioma | ClinVar | PMID:25741868 more ... | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
Imported Disease Annotations - CTD
Imported Disease Annotations - OMIM
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
RGD Manual Annotations
Imported Annotations - SMPDB
Imported Annotations - KEGG (archival)
Imported Annotations - PID (archival)
Phenotype Annotations Click to see Annotation Detail View
Mammalian Phenotype
Disease Annotations
Click to see Annotation Detail View
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
|
|
|
Gene Ontology Annotations
Click to see Annotation Detail View
Biological Process
|
|
|
Cellular Component
|
|
|
Molecular Function
|
|
|
Molecular Pathway Annotations
Click to see Annotation Detail View
|
|
|
Phenotype Annotations
Click to see Annotation Detail View
Mammalian Phenotype
|
|
|
References
References - curated
| # | Reference Title | Reference Citation |
| 1. | Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas. | Angelov L, etal., Cancer Res. 1999 Nov 1;59(21):5536-41. |
| 2. | Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma. | Arita S, etal., Int J Gynecol Cancer. 2005 Mar-Apr;15(2):329-36. |
| 3. | Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria. | Aucejo F, etal., Liver Transpl. 2009 Feb;15(2):169-76. doi: 10.1002/lt.21678. |
| 4. | Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats. | Azizi Y, etal., Eur J Pharmacol. 2015 Aug 15;761:101-8. doi: 10.1016/j.ejphar.2015.04.034. Epub 2015 May 1. |
| 5. | EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer. | Badalian G, etal., Anticancer Res. 2007 Mar-Apr;27(2):889-94. |
| 6. | [Expression of kinase insert domain-containing receptor in prostate adenocarcinoma] | Bai AS, etal., Zhonghua Nan Ke Xue. 2007 Apr;13(4):324-6. |
| 7. | Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. | Beca F, etal., Mod Pathol. 2020 Aug;33(8):1518-1526. doi: 10.1038/s41379-020-0511-6. Epub 2020 Mar 2. |
| 8. | Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy. | Beebe JS, etal., Cancer Res. 2003 Nov 1;63(21):7301-9. |
| 9. | Vascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the rat. | Bott RC, etal., Biol Reprod. 2006 Jul;75(1):56-67. Epub 2006 May 3. |
| 10. | Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics. | Brennan M, etal., Eur J Clin Pharmacol. 2012 May;68(5):645-55. Epub 2011 Dec 15. |
| 11. | Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. | Brockington A, etal., J Neuropathol Exp Neurol. 2006 Jan;65(1):26-36. |
| 12. | Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. | Brown LF, etal., J Immunol. 1995 Mar 15;154(6):2801-7. |
| 13. | Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. | Bruno S, etal., Cytokine. 2006 Apr;34(1-2):56-65. Epub 2006 May 15. |
| 14. | The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer. | Butkiewicz D, etal., Int J Cancer. 2015 Nov 15;137(10):2332-42. doi: 10.1002/ijc.29605. Epub 2015 Jun 3. |
| 15. | VEGF links hippocampal activity with neurogenesis, learning and memory. | Cao L, etal., Nat Genet. 2004 Aug;36(8):827-35. Epub 2004 Jul 18. |
| 16. | Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. | Carrai V, etal., Rheumatology (Oxford). 2012 Jun;51(6):1042-8. doi: 10.1093/rheumatology/ker447. Epub 2012 Jan 23. |
| 17. | KDR activation in astrocytic neoplasms. | Carroll RS, etal., Cancer. 1999 Oct 1;86(7):1335-41. |
| 18. | Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. | Chae SS, etal., Clin Cancer Res. 2010 Jul 15;16(14):3618-27. Epub 2010 May 25. |
| 19. | Expression of vascular endothelial growth factor receptors in experimental otitis media in the rat. | Chae SW, etal., Acta Otolaryngol. 2003 Jun;123(5):559-63. |
| 20. | The role of KDR in intrauterine adhesions may involve the TGF-β1/Smads signaling pathway. | Chen JX, etal., Braz J Med Biol Res. 2019 Oct 7;52(10):e8324. doi: 10.1590/1414-431X20198324. eCollection 2019. |
| 21. | Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 following acute spinal cord contusion in rats. | Choi JS, etal., J Histochem Cytochem. 2007 Aug;55(8):821-30. Epub 2007 Apr 4. |
| 22. | Upregulation of vascular endothelial growth factor receptors Flt-1 and Flk-1 in rat hippocampus after transient forebrain ischemia. | Choi JS, etal., J Neurotrauma. 2007 Mar;24(3):521-31. |
| 23. | Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model. | Conrad C, etal., Anticancer Drugs. 2007 Jun;18(5):569-79. doi: 10.1097/CAD.0b013e3280147d13. |
| 24. | rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. | Davidoff AM, etal., Cancer Res. 2002 Jun 1;62(11):3077-83. |
| 25. | Arteriogenic erectile dysfunction alters protein expression within the cavernosal tissue in an animal model. | De Young L, etal., J Sex Med. 2005 Mar;2(2):199-206. |
| 26. | [Expression of vascular endothelial growth factor receptor kinase inser domain containing receptor in human cervical carcinoma]. | Di H, etal., Zhonghua Fu Chan Ke Za Zhi. 2000 Nov;35(11):670-2. |
| 27. | Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance. | Ding M, etal., Chin J Cancer Res. 2014 Dec;26(6):669-77. doi: 10.3978/j.issn.1000-9604.2014.12.04. |
| 28. | Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer. | Dong G, etal., Cancer Sci. 2012 Mar;103(3):561-8. doi: 10.1111/j.1349-7006.2011.02194.x. Epub 2012 Jan 16. |
| 29. | Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. | Fadini GP, etal., Stroke. 2006 Sep;37(9):2277-82. Epub 2006 Jul 27. |
| 30. | Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis. | Fan L, etal., Nephron 2002 Jan;90(1):95-102. |
| 31. | Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats. | Feng Y, etal., Neuroscience. 2011 Apr 14;179:223-32. Epub 2011 Jan 28. |
| 32. | Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. | Fernandez M, etal., Gastroenterology. 2004 Mar;126(3):886-94. |
| 33. | Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor. | Foster KA, etal., Neurosci Res. 2009 Jan;63(1):10-6. Epub 2008 Oct 4. |
| 34. | Diversity of immunophenotypes of endothelial cells participating in new vessel formation following surgical rat brain injury. | Frontczak-Baniewicz M, etal., J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 1):193-203. |
| 35. | Non-endothelial KDR/flk-1 expression is associated with increased survival of patients with urothelial bladder carcinomas. | Gakiopoulou-Givalou H, etal., Histopathology. 2003 Sep;43(3):272-9. |
| 36. | Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. | Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27. |
| 37. | Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia. | Gebhardt M, etal., Ophthalmology. 2005 Jun;112(6):1023-30. |
| 38. | The angiogenic "vascular endothelial growth factor/flk-1(KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. | Giatromanolaki A, etal., Cancer. 2001 Nov 15;92(10):2569-77. |
| 39. | Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2alpha and survival. | Giatromanolaki A, etal., Clin Exp Metastasis. 2012 Jan;29(1):11-7. doi: 10.1007/s10585-011-9424-6. Epub 2011 Oct 9. |
| 40. | Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis. | Giatromanolaki A, etal., Mod Pathol. 2006 May;19(5):701-7. |
| 41. | Rat ISS GO annotations from GOA human gene data--August 2006 | GOA data from the GO Consortium |
| 42. | Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. | Gomez R, etal., Endocrinology 2002 Nov;143(11):4339-48. |
| 43. | Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate. | Gumus K, etal., Br J Ophthalmol. 2013 Feb 1. |
| 44. | [The significance and expression of vascular endothelial growth factor on nasal inverted papillomas]. | Han FJ, etal., Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000 Feb;14(2):65-7. |
| 45. | Minor salivary gland carcinoma: a review of 35 cases. | Haymerle G, etal., Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2717-26. doi: 10.1007/s00405-015-3805-4. Epub 2015 Oct 23. |
| 46. | Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation. | Heffelfinger SC, etal., Lab Invest. 2004 Aug;84(8):989-98. |
| 47. | Histological and transcriptional study of angiogenesis and lymphangiogenesis in uninvolved skin, acute pinpoint lesions and established psoriasis plaques: an approach of vascular development chronology in psoriasis. | Henno A, etal., J Dermatol Sci. 2010 Mar;57(3):162-9. doi: 10.1016/j.jdermsci.2009.12.006. Epub 2010 Jan 7. |
| 48. | Polymorphisms in Vascular Endothelial Growth Factor Receptor 2 Are Associated with Better Response Rates to Ranibizumab Treatment in Age-related Macular Degeneration. | Hermann MM, etal., Ophthalmology. 2013 Dec 20. pii: S0161-6420(13)01056-7. doi: 10.1016/j.ophtha.2013.10.047. |
| 49. | Expression pattern of VEGFR-1, -2, -3 and D2-40 protein in the skin of patients with systemic sclerosis. | Higashi-Kuwata N, etal., Eur J Dermatol. 2011 Jul-Aug;21(4):490-4. doi: 10.1684/ejd.2011.1284. |
| 50. | Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. | Holmes K, etal., Cell Signal. 2007 Oct;19(10):2003-12. Epub 2007 Jun 12. |
| 51. | Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. | Huang H, etal., PLoS One. 2011;6(6):e21411. Epub 2011 Jun 22. |
| 52. | Dietary alpha-linolenic acid-rich formula reduces adhesion molecules in rats with experimental colitis. | Ibrahim A, etal., Nutrition. 2012 Jul;28(7-8):799-802. doi: 10.1016/j.nut.2011.10.008. Epub 2012 Jan 20. |
| 53. | Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors. | Inan S, etal., Histol Histopathol. 2006 Oct;21(10):1055-64. |
| 54. | Differential gene expression of vascular endothelial growth factor isoforms and their receptors in the development of the rat masseter muscle. | Ishii H, etal., Arch Oral Biol 2002 Jul;47(7):505-10. |
| 55. | Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib. | Jain L, etal., J Exp Clin Cancer Res. 2010 Jul 14;29:95. doi: 10.1186/1756-9966-29-95. |
| 56. | Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC. | Jantus-Lewintre E, etal., Lung Cancer. 2011 Nov;74(2):326-31. doi: 10.1016/j.lungcan.2011.02.016. Epub 2011 Apr 9. |
| 57. | Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart. | Jesmin S, etal., Exp Biol Med (Maywood). 2006 Jun;231(6):902-6. |
| 58. | Time-Dependent Alterations of VEGF and Its Signaling Molecules in Acute Lung Injury in a Rat Model of Sepsis. | Jesmin S, etal., Inflammation. 2011 Apr 29. |
| 59. | Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker. | Jesmin S, etal., J Cardiovasc Pharmacol. 2004 Nov;44 Suppl 1:S160-4. |
| 60. | Vascular endothelial growth factor stimulates neurite outgrowth from cerebral cortical neurons via Rho kinase signaling. | Jin K, etal., J Neurobiol. 2006 Feb 15;66(3):236-42. |
| 61. | Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis. | Jinnin M, etal., Br J Dermatol. 2010 Apr;162(4):751-8. doi: 10.1111/j.1365-2133.2009.09567.x. Epub 2009 Nov 3. |
| 62. | Blockade of the vascular endothelial growth factor-receptor 2 pathway inhibits the growth of human renal cell carcinoma, RBM1-IT4, in the kidney but not in the bone of nude mice. | Karashima T, etal., Int J Oncol. 2007 Apr;30(4):937-45. |
| 63. | Expression of vascular endothelial growth factor in eyes with Coats' disease. | Kase S, etal., Invest Ophthalmol Vis Sci. 2013 Jan 7;54(1):57-62. doi: 10.1167/iovs.12-10613. |
| 64. | Receptor protein tyrosine kinases in perinatal developing rat kidney. | Kee N, etal., Kidney Int. 1997 Aug;52(2):309-17. |
| 65. | DCE-MRI in Glioma, Infiltration Zone and Healthy Brain to Assess Angiogenesis: AÂ Biopsy Study. | Keil VC, etal., Clin Neuroradiol. 2021 Dec;31(4):1049-1058. doi: 10.1007/s00062-021-01015-3. Epub 2021 Apr 26. |
| 66. | Inhibitory effects of SU5416, a selective vascular endothelial growth factor receptor tyrosine kinase inhibitor, on experimental corneal neovascularization. | Keskin U, etal., Ophthalmic Res. 2012;47(1):13-8. doi: 10.1159/000324994. Epub 2011 Jun 21. |
| 67. | Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. | Kim B, etal., J Immunol. 2006 Sep 15;177(6):4122-31. |
| 68. | Vascular endothelial growth factor (VEGF) signaling regulates hippocampal neurons by elevation of intracellular calcium and activation of calcium/calmodulin protein kinase II and mammalian target of rapamycin. | Kim BW, etal., Cell Signal. 2008 Apr;20(4):714-25. Epub 2007 Dec 17. |
| 69. | Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis. | Kim DG, etal., MAbs. 2015;7(6):1195-204. doi: 10.1080/19420862.2015.1086854. Epub 2015 Sep 1. |
| 70. | Distinct roles of vascular endothelial growth factor receptor-1- and receptor-2-mediated signaling in T cell priming and Th17 polarization to lipopolysaccharide-containing allergens in the lung. | Kim YS, etal., J Immunol. 2010 Nov 1;185(9):5648-55. Epub 2010 Oct 4. |
| 71. | Inhibition of retinal and choroidal neovascularization by a novel KDR kinase inhibitor. | Kinose F, etal., Mol Vis. 2005 May 27;11:366-73. |
| 72. | Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. | Kivela R, etal., FASEB J. 2006 Jul;20(9):1570-2. |
| 73. | Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. | Kranenburg AR, etal., Thorax. 2005 Feb;60(2):106-13. |
| 74. | Molecular mediators of tumor angiogenesis: enhanced expression and activation of vascular endothelial growth factor receptor KDR in primary breast cancer. | Kranz A, etal., Int J Cancer. 1999 Jun 21;84(3):293-8. |
| 75. | Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects. | Krishnan ST, etal., Diabetes Care. 2007 Dec;30(12):3058-62. Epub 2007 Sep 26. |
| 76. | Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. | Krum JM, etal., Neuroscience. 2002;110(4):589-604. |
| 77. | Hind-limb paraparesis in a rat model for neurolathyrism associated with apoptosis and an impaired vascular endothelial growth factor system in the spinal cord. | Kusama-Eguchi K, etal., J Comp Neurol. 2010 Mar 15;518(6):928-42. |
| 78. | The rs2071559 AA VEGFR-2 genotype frequency is significantly lower in neovascular age-related macular degeneration patients. | Lazzeri S, etal., ScientificWorldJournal. 2012;2012:420190. doi: 10.1100/2012/420190. Epub 2012 Aug 1. |
| 79. | Inhibition of VEGF receptor 2 increased cell death of dentate hilar neurons after traumatic brain injury. | Lee C and Agoston DV, Exp Neurol. 2009 Dec;220(2):400-3. Epub 2009 Sep 3. |
| 80. | TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis. | Lee WS, etal., MAbs. 2015;7(5):957-68. doi: 10.1080/19420862.2015.1045168. Epub 2015 May 5. |
| 81. | KDR (VEGF receptor 2) is the major mediator for the hypotensive effect of VEGF. | Li B, etal., Hypertension. 2002 Jun;39(6):1095-100. |
| 82. | VEGF and its receptor-2 involved in neuropathic pain transmission mediated by P2X(/) receptor of primary sensory neurons. | Lin J, etal., Brain Res Bull. 2010 Oct 30;83(5):284-91. Epub 2010 Aug 10. |
| 83. | Inverse correlation of phospho-KDR/Flk-1 expression and stage of colorectal cancer: implication of the significance of neoangiogenesis in activated VEGFR-2 expressing early stage colorectal adenocarcinomas. | Lin YF, etal., Pol J Pathol. 2014 Oct;65(3):194-201. doi: 10.5114/pjp.2014.45781. |
| 84. | Multiple receptor tyrosine kinases are expressed in adult rat retinal ganglion cells as revealed by single-cell degenerate primer polymerase chain reaction. | Lindqvist N, etal., Ups J Med Sci. 2010 Feb;115(1):65-80. doi: 10.3109/03009731003597119. |
| 85. | Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. | Lionetti V, etal., J Biol Chem. 2010 Mar 26;285(13):9949-61. doi: 10.1074/jbc.M109.087254. Epub 2010 Jan 22. |
| 86. | Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder. | Liu L, etal., Urol Int. 2008;81(1):72-6. Epub 2008 Jul 16. |
| 87. | [Pathogenesis of retinal neovascularization in a rat model of oxygen fluctuations-induced retinopathy]. | Liu X, etal., Zhonghua Er Ke Za Zhi. 2007 Jan;45(1):7-13. |
| 88. | Ponicidin induces apoptosis via JAK2 and STAT3 signaling pathways in gastric carcinoma. | Liu YF, etal., Int J Mol Sci. 2015 Jan 12;16(1):1576-89. doi: 10.3390/ijms16011576. |
| 89. | In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. | Lungu GF, etal., Int J Oncol. 2007 Jan;30(1):45-54. |
| 90. | A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. | Machado DE, etal., Fertil Steril. 2010 May 15;93(8):2674-9. Epub 2010 Jan 13. |
| 91. | Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis. | Machado MV, etal., Eur J Gastroenterol Hepatol. 2014 Apr;26(4):438-43. doi: 10.1097/MEG.0000000000000044. |
| 92. | Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition. | Marwick JA, etal., Am J Physiol Lung Cell Mol Physiol. 2006 May;290(5):L897-908. Epub 2005 Dec 16. |
| 93. | Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension. | Masaki T, etal., Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2023899118. doi: 10.1073/pnas.2023899118. |
| 94. | [Prognostic significance of serum level of vascular endothelial growth factor receptor-2 in hepatocellular carcinoma patients after transcatheter arterial chemoembolization]. | Meng QW, etal., Zhonghua Yi Xue Za Zhi. 2013 Jan 29;93(5):341-4. |
| 95. | Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. | Meunier-Carpentier S, etal., Int J Oncol. 2005 Apr;26(4):977-84. |
| 96. | Rat ISS GO annotations from MGI mouse gene data--August 2006 | MGD data from the GO Consortium |
| 97. | Rapid vessel regression, protease inhibition, and stromal normalization upon short-term vascular endothelial growth factor receptor 2 inhibition in skin carcinoma heterotransplants. | Miller DW, etal., Am J Pathol. 2005 Nov;167(5):1389-403. |
| 98. | Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer. | Miyazawa M, etal., Cancer Sci. 2010 Feb;101(2):433-9. Epub 2009 Oct 27. |
| 99. | Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. | Mochimaru H, etal., Invest Ophthalmol Vis Sci. 2008 May;49(5):2172-7. doi: 10.1167/iovs.07-1396. Epub 2008 Feb 8. |
| 100. | KLF5/BTEB2, a Kruppel-like zinc-finger type transcription factor, mediates both smooth muscle cell activation and cardiac hypertrophy. | Nagai R, etal., Adv Exp Med Biol 2003;538:57-65; discussion 66. |
| 101. | Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation. | Nakopoulou L, etal., Hum Pathol. 2002 Sep;33(9):863-70. |
| 102. | Electronic Transfer of LocusLink and RefSeq Data | NCBI rat LocusLink and RefSeq merged data July 26, 2002 |
| 103. | A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. | Niethammer AG, etal., Nat Med. 2002 Dec;8(12):1369-75. doi: 10.1038/nm1202-794. Epub 2002 Nov 4. |
| 104. | Association of inflammatory factors with macular edema in branch retinal vein occlusion. | Noma H, etal., JAMA Ophthalmol. 2013 Feb;131(2):160-5. doi: 10.1001/2013.jamaophthalmol.228. |
| 105. | Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas. | Norgall S, etal., BMC Cancer. 2007 Jun 21;7:105. |
| 106. | Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. | Nykanen AI, etal., Transplantation. 2005 Jan 27;79(2):182-9. |
| 107. | VEGF receptor signalling - in control of vascular function. | Olsson AK, etal., Nat Rev Mol Cell Biol. 2006 May;7(5):359-71. |
| 108. | OMIM Disease Annotation Pipeline | OMIM Disease Annotation Pipeline |
| 109. | Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells. | Parthymou A, etal., Eur J Cell Biol. 2008 Jan;87(1):17-29. Epub 2007 Sep 18. |
| 110. | Immunohistochemical study of VEGF, angiopoietin 2 and their receptors in the neovascularization following microinjection of C6 glioma cells into rat brain. | Peoch M, etal., Anticancer Res 2002 Jul-Aug;22(4):2147-51. |
| 111. | DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. | Petrovan RJ, etal., Arterioscler Thromb Vasc Biol. 2007 May;27(5):1095-100. Epub 2007 Feb 15. |
| 112. | VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. | Pieh C, etal., Br J Ophthalmol. 2008 May;92(5):689-93. doi: 10.1136/bjo.2007.128371. Epub 2008 Apr 11. |
| 113. | Activation of multiple angiogenic signaling pathways in hemangiopericytoma. | Pierscianek D, etal., Brain Tumor Pathol. 2016 Jul;33(3):200-8. doi: 10.1007/s10014-016-0256-6. Epub 2016 Mar 7. |
| 114. | KEGG Annotation Import Pipeline | Pipeline to import KEGG annotations from KEGG into RGD |
| 115. | PID Annotation Import Pipeline | Pipeline to import Pathway Interaction Database annotations from NCI into RGD |
| 116. | SMPDB Annotation Import Pipeline | Pipeline to import SMPDB annotations from SMPDB into RGD |
| 117. | VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas. | Pisacane AM and Risio M, Melanoma Res. 2005 Feb;15(1):39-43. |
| 118. | The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers. | Pufe T, etal., J Pathol. 2003 May;200(1):130-6. |
| 119. | Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy. | Ran S, etal., Neoplasia. 2003 Jul-Aug;5(4):297-307. |
| 120. | Soluble Vascular Endothelial Growth Factor Receptor-2 as a Predictive Factor for Progression of Illness in Chronic Liver Diseases and Hepatocellular Carcinoma. | Ratnasari N, etal., Kobe J Med Sci. 2015 Dec 18;61(3):E89-96. |
| 121. | Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. | Renno RZ, etal., Arch Ophthalmol. 2004 Jul;122(7):1002-11. |
| 122. | GOA pipeline | RGD automated data pipeline |
| 123. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
| 124. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
| 125. | Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer. | Roland CL, etal., PLoS One. 2009 Nov 3;4(11):e7669. |
| 126. | VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. | Roscoe WA, etal., J Neuroimmunol. 2009 Apr 30;209(1-2):6-15. Epub 2009 Feb 23. |
| 127. | The effect of combination anti-endothelial growth factor receptor and anti-vascular endothelial growth factor receptor 2 targeted therapy on lymph node metastasis: a study in an orthotopic nude mouse model of squamous cell carcinoma of the oral tongue. | Sano D, etal., Arch Otolaryngol Head Neck Surg. 2009 Apr;135(4):411-20. doi: 10.1001/archoto.2009.14. |
| 128. | Flt1 and Flk1 mediate regulation of intraocular pressure and their double heterozygosity causes the buphthalmia in mice. | Sano K, etal., Biochem Biophys Res Commun. 2012 Apr 6;420(2):422-7. doi: 10.1016/j.bbrc.2012.03.011. Epub 2012 Mar 9. |
| 129. | Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. | Sasso FC, etal., J Am Coll Cardiol. 2005 Sep 6;46(5):827-34. |
| 130. | VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. | Scaldaferri F, etal., Gastroenterology. 2009 Feb;136(2):585-95.e5. Epub 2008 Oct 7. |
| 131. | Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation. | Schmid-Brunclik N, etal., Am J Physiol Regul Integr Comp Physiol. 2008 Sep;295(3):R864-73. Epub 2008 Jul 9. |
| 132. | Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome. | Scotti L, etal., J Steroid Biochem Mol Biol. 2014 Oct;144 Pt B:392-401. doi: 10.1016/j.jsbmb.2014.08.013. Epub 2014 Aug 23. |
| 133. | Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer. | Seto T, etal., Lung Cancer. 2006 Jul;53(1):91-6. doi: 10.1016/j.lungcan.2006.02.009. Epub 2006 May 11. |
| 134. | [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma]. | Sha D and He YJ, Ai Zheng. 2006 Feb;25(2):229-34. |
| 135. | Zhonghua nan ke xue = National journal of andrology | Shao JC, etal., Zhonghua Nan Ke Xue. 2005 Jun;11(6):413-8. |
| 136. | Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. | Shimotake J, etal., Stroke. 2010 Feb;41(2):343-9. |
| 137. | Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia. | Shiote M, etal., Neuroscience. 2005;132(1):175-82. |
| 138. | Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients. | Shuwen H, etal., Dis Markers. 2020 Jun 16;2020:9369341. doi: 10.1155/2020/9369341. eCollection 2020. |
| 139. | VEGF and VEGF receptor expression after experimental brain contusion in rat. | Skold MK, etal., J Neurotrauma. 2005 Mar;22(3):353-67. |
| 140. | Vascular therapy for radiation cystitis. | Soler R, etal., Neurourol Urodyn. 2011 Mar;30(3):428-34. doi: 10.1002/nau.21002. Epub 2010 Oct 29. |
| 141. | Normal aging involves altered expression of growth factors in the rat choroid. | Steinle JJ, etal., J Gerontol A Biol Sci Med Sci. 2008 Feb;63(2):135-40. |
| 142. | Gamma-Secretase Inhibitor, DAPT, Prevents the Development of Retinopathy of Prematurity in a Rat Model by Regulating the Delta-Like Ligand 4/Notch Homolog-1 (DLL4/Notch-1) Pathway. | Sun W, etal., Med Sci Monit. 2019 Jan 17;25:492-499. doi: 10.12659/MSM.913828. |
| 143. | Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo. | Takahashi H, etal., Curr Eye Res. 2008 Nov;33(11):1002-10. doi: 10.1080/02713680802492440. |
| 144. | Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model. | Takahashi H, etal., Invest Ophthalmol Vis Sci. 2008 May;49(5):2143-7. doi: 10.1167/iovs.07-0523. |
| 145. | The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts. | Takahashi T and Shibuya M, Oncogene. 1997 May 1;14(17):2079-89. |
| 146. | Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor. | Takeda A, etal., Graefes Arch Clin Exp Ophthalmol. 2003 Sep;241(9):765-72. Epub 2003 Aug 23. |
| 147. | Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. | Tardy I, etal., Invest Radiol. 2010 Oct;45(10):573-8. |
| 148. | Tentative Sequence Identification Numbers | Tentative Sequence Data IDs. TIGR Gene Index, Rat Data |
| 149. | Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). | Uehara H, etal., FASEB J. 2013 Jan;27(1):76-85. doi: 10.1096/fj.12-213835. Epub 2012 Sep 20. |
| 150. | Expression of VEGF and its receptor genes in intracranial schwannomas. | Uesaka T, etal., J Neurooncol. 2007 Jul;83(3):259-66. Epub 2007 Feb 14. |
| 151. | Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. | Uranishi R, etal., Neurosurgery. 2001 Feb;48(2):359-67; discussion 367-8. |
| 152. | Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. | Vajkoczy P, etal., J Clin Invest 2002 Mar;109(6):777-85. |
| 153. | Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab. | Vihinen PP, etal., Melanoma Res. 2011 Oct;21(5):431-7. doi: 10.1097/CMR.0b013e32834941d3. |
| 154. | VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. | Waldner MJ, etal., J Exp Med. 2010 Dec 20;207(13):2855-68. Epub 2010 Nov 22. |
| 155. | Zhonghua bing li xue za zhi Chinese journal of pathology | Wang H, etal., Zhonghua Bing Li Xue Za Zhi. 2002 Oct;31(5):391-5. |
| 156. | VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. | Warner-Schmidt JL and Duman RS, Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4647-52. Epub 2007 Mar 5. |
| 157. | Anti-vascular endothelial growth factor receptor-2 (Flk-1/KDR) antibody suppresses contact hypersensitivity. | Watanabe H, etal., Exp Dermatol. 2004 Nov;13(11):671-81. |
| 158. | Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1. | Wen Y, etal., Biochem Biophys Res Commun. 1999 May 19;258(3):713-21. |
| 159. | Two functional forms of vascular endothelial growth factor receptor-2/Flk-1 mRNA are expressed in normal rat retina. | Wen Y, etal., J Biol Chem 1998 Jan 23;273(4):2090-7. |
| 160. | Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. | Wilkinson-Berka JL, etal., Am J Pathol. 2004 Apr;164(4):1263-73. |
| 161. | Induction of angiogenesis and modulation of vascular endothelial growth factor receptor-2 by simvastatin after traumatic brain injury. | Wu H, etal., Neurosurgery. 2011 May;68(5):1363-71; discussion 1371. |
| 162. | Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. | Wu IC, etal., Neoplasia. 2011 Apr;13(4):386-92. doi: 10.1593/neo.101722. |
| 163. | Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. | Xia G, etal., J Urol. 2006 Apr;175(4):1245-52. |
| 164. | A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis. | Yan HX, etal., Mol Med Rep. 2013 Aug;8(2):434-8. doi: 10.3892/mmr.2013.1500. Epub 2013 May 31. |
| 165. | Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy. | Yang F, etal., Cancer Res. 2011 Aug 15;71(16):5512-21. doi: 10.1158/0008-5472.CAN-10-2614. Epub 2011 Jul 1. |
| 166. | Expression and significance of the vascular permeability factor in nasal polyps. | Yang J, etal., Chin Med J (Engl). 2002 Aug;115(8):1251-2. |
| 167. | Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors. | Yazawa H, etal., Cancer Gene Ther. 2006 Nov;13(11):993-1001. doi: 10.1038/sj.cgt.7700970. Epub 2006 Jun 9. |
| 168. | Non-viral delivery of interleukin-2 and soluble Flk-1 inhibits metastatic and primary tumor growth in renal cell carcinoma. | Yockman JW, etal., Gene Ther. 2007 Oct;14(19):1399-405. Epub 2007 Jul 26. |
| 169. | Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component. | Yuksel H, etal., Clin Exp Allergy. 2007 Aug;37(8):1183-8. |
| 170. | Two isoforms of flk-1 transcripts in early diabetic rat retinas. | Zhang X, etal., Curr Eye Res. 2012 Jan;37(1):73-9. Epub 2011 Nov 28. |
| 171. | Extracellular domain of kinase domain region mediated by adeno-associated virus inhibits growth and angiogenesis of bladder cancer in Balb-c mice. | Zhang Z, etal., Chin Med J (Engl). 2002 Aug;115(8):1209-12. |
| 172. | The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib. | Zheng YB, etal., Med Oncol. 2014 Oct;31(10):209. doi: 10.1007/s12032-014-0209-z. Epub 2014 Sep 3. |
| 173. | The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer. | Zhu X, etal., Cancer Biol Ther. 2019;20(4):497-504. doi: 10.1080/15384047.2018.1537575. Epub 2018 Oct 31. |
| 174. | Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy. | Zhuang PY, etal., Oncotarget. 2014 Nov 30;5(22):11121-32. doi: 10.18632/oncotarget.2553. |
| 175. | Orally administered DNA vaccine delivery by attenuated Salmonella typhimurium targeting fetal liver kinase 1 inhibits murine Lewis lung carcinoma growth and metastasis. | Zuo SG, etal., Biol Pharm Bull. 2010;33(2):174-82. doi: 10.1248/bpb.33.174. |
Additional References at PubMed
| PMID:1323289 | PMID:1417831 | PMID:7596435 | PMID:7681362 | PMID:7929439 | PMID:7999104 | PMID:8356051 | PMID:9398617 | PMID:9804796 | PMID:9837777 | PMID:10022831 | PMID:10037737 |
| PMID:10102632 | PMID:10600473 | PMID:10705382 | PMID:10878616 | PMID:11387210 | PMID:11950700 | PMID:11967019 | PMID:12053176 | PMID:12477932 | PMID:12569129 | PMID:12631117 | PMID:12753865 |
| PMID:12820653 | PMID:12897140 | PMID:12923895 | PMID:14766216 | PMID:15215251 | PMID:15548727 | PMID:15601856 | PMID:15644447 | PMID:15734877 | PMID:15919309 | PMID:15962004 | PMID:16010973 |
| PMID:16099728 | PMID:16375885 | PMID:16455951 | PMID:16901919 | PMID:16944045 | PMID:17050862 | PMID:17293873 | PMID:17418870 | PMID:17651752 | PMID:17854994 | PMID:17889862 | PMID:18174522 |
| PMID:18321563 | PMID:18421240 | PMID:18462699 | PMID:18482723 | PMID:18586890 | PMID:18772315 | PMID:18835919 | PMID:18977327 | PMID:19033661 | PMID:19357264 | PMID:19426150 | PMID:19513111 |
| PMID:19575935 | PMID:19635461 | PMID:19774558 | PMID:20080685 | PMID:20103598 | PMID:20116868 | PMID:20228271 | PMID:20406889 | PMID:20439428 | PMID:20497492 | PMID:20550877 | PMID:20572782 |
| PMID:20599605 | PMID:20637183 | PMID:20660291 | PMID:20697002 | PMID:21418372 | PMID:21435466 | PMID:21613481 | PMID:21885851 | PMID:21928073 | PMID:22245234 | PMID:22265737 | PMID:22499991 |
| PMID:22569153 | PMID:22886301 | PMID:22949406 | PMID:23262137 | PMID:23348691 | PMID:23456363 | PMID:23529610 | PMID:23639442 | PMID:23684887 | PMID:23688497 | PMID:23732519 | PMID:23798385 |
| PMID:23826635 | PMID:23831211 | PMID:24022223 | PMID:24063000 | PMID:24205206 | PMID:24398936 | PMID:24623966 | PMID:24630601 | PMID:24863063 | PMID:25195697 | PMID:25730004 | PMID:25754303 |
| PMID:25893857 | PMID:26509169 | PMID:26879375 | PMID:27439004 | PMID:27733124 | PMID:28457321 | PMID:28637396 | PMID:28958753 | PMID:29710417 | PMID:30816491 | PMID:30873824 | PMID:31406128 |
| PMID:31583245 | PMID:32189115 | PMID:32481647 | PMID:32918705 | PMID:33008083 | PMID:33671638 | PMID:33904385 | PMID:34169992 |
Genomics
Comparative Map Data
| Kdr (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDR (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kdr (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kdr (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDR (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDR (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kdr (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDR (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| KDR (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Kdr (Heterocephalus glaber - naked mole-rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variants
.
Variants in Kdr
168 total Variants 
|
